| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8659631bf38b3a590c0d3edc265492c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-676 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-255 |
| filingDate |
1987-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65eaeeca74b0075aecc3a269c8896a0d |
| publicationDate |
1989-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CH-670083-A5 |
| titleOfInvention |
antiinflammatory 4-naphthyl-2-butanone deriv. prodn. |
| abstract |
(A)3-Allyloxycarbonyl- 4-(6-methoxy-2- naphthyl)- 3-buten-2-one of formula (IIa) is new: (B) Prodn. of 4-(6-methoxy-2-naphthyl)-2-butanone (I) is effected by catalytic transfer hydrogenation of a cpd. of formula (II) in the presence of cyclohexene (III): X and Y are H, or X+Y is a bond; R1 is COOH or an ester gp convertible to COOH by hydrogenation, (allyl, benzyl or p-methoxybenzyl). |
| priorityDate |
1986-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |